81N-033P Antiplaque & Antiplaque-Related Claims

SUP 1 Colgate-Palmolive Company Vol#: 1

94P-0429 Establish the Proper Composition of Conjugated Estrogens

WDL 1 Wyeth-Ayerst Laboratories Vol#: 22

94P-0430 Stay of Action of Approval of ANDAs for Conjugated Estrogens

WDL 1 Wyeth-Ayerst Laboratories Vol#: 1

01N-0067 Reclassification of Dental Mercury

C 55 Consumers for Dental Choice Vol#: 8

C 56 Consumers for Dental Choice Vol#: 8

C 57 Mrs. James (Dorothy) Edington Vol#: 8

C 58 Anne O. Summers, PhD Vol#: 8

C 59 Oregon Doctors of Chiropractic Vol#: 8

C 60 Consumers for Dental Choice Vol#: 8

C 61 Consumers for Dental Choice Vol#: 8

C 62 James E. Hardy, DMD Vol#: 8

C 63 Bay of Plenty Environmental Health Clini Vol#: 8

C 64 Citizens for Health Freedom Vol#: 9

C 65 University of Louisville Vol#: 8

01P-0120 Ban Unsafe IV Catheters and other Devices

C 6 ECRI Vol#: 1

C 7 Retractable Technologies, Inc. Vol#: 1

C 8 Sterimatic, Ltd. Vol#: 1

01P-0230 Domestic Marketing & Importation of Transgenic Fish

C 1116 Candice J. Hartman Vol#: 221

C 1117 Virginia Fabilli Vol#: 221

C 1118 Barbara L. Thompson Vol#: 221

C 1119 J. Dashe Vol#: 221

C 1120 Eleanor MacLellan Vol#: 221

C 1121 Wally Warm Vol#: 221

C 1122 Kathleen Warm Vol#: 221

C 1123 Elizabeth Bjorkman Vol#: 221

C 1124 Wendy C. Hayes Vol#: 221

C 1125 Peter & Cami Elbow Vol#: 221

C 1126 Montserrat Archbald Vol#: 221

C 1127 Norm Andresen Vol#: 221

02D-0228 Implantable Middle Ear Hearing Device

C 6 American Academy of Audiology Vol#: 1

02D-0324 Bioengineered Plants for Use in Humans and Animals

GDL 1 Guideline Vol#: 1

NAD 1 Vol#: 1

02D-0333 Juice HACCP Hazards and Controls

GDL 1 Guideline Vol#: 1

NAD 1 Vol#: 1

02M-0409 HDE Neuroform Microdelivery Stent System, H02002

AAV 1 SMART Therapeutics Inc Vol#: 1

02N-0115 Risk Management of Prescription Drugs; Public Hearing

TR 1 Part 15 Hearing Held 05/22/02 Vol#: 4

02N-0209 Governing First Amendment Case Law

C 32 Pfizer, Inc. Vol#: 10

C 33 National Food Processors Assn. (NFPA) Vol#: 15

C 34 CTFA Vol#: 15

C 35 AHI, Animal Health Institute Vol#: 15

C 36 Newspaper Assn. of America (NAA) Vol#: 15

C 37 American Academy of Pediatrics Vol#: 15

C 38 King & Spalding Vol#: 15

C 39 Johnson & Johnson Vol#: 15

C 40 AARP Vol#: 15

C 41 Public Citizen Research Group Vol#: 15

C 42 Health Resource Publishing Co. Vol#: 15

C 43 Hyman, Phelps & McNamara, P.C. Vol#: 15

C 44 National Center for Tobacco-Free Kids, I Vol#: 15

C 45 National Assn. of Margarine Mfrs. Vol#: 15

C 46 PhRMA Vol#: 16

C 47 NVCA, National Venture Capital Assn. Vol#: 16

C 48 Cook Group, Inc. Vol#: 16

C 49 AdvaMed, Advanced Medical Technology Ass Vol#: 16

C 50 Yvette Lloyd Vol#: 16

C 51 Patricia Simmons Vol#: 16

C 52 ASCO, American Society of Clinical Oncol Vol#: 16

C 53 Center for Constitutional Rights Vol#: 16

C 54 Freedom of Expression Foundation, Inc. Vol#: 16

C 55 Glenn H. Martin Vol#: 16

C 56 Nancy A. Rader Vol#: 16

C 57 MPA, Magazine Publishers of America Vol#: 16

C 58 Medtronic, Inc. Vol#: 16

02N-0393 Draft Action Plan on Acrylamide

NM 1 Meeting on 9/30/02 Vol#: 1

02P-0392 Determine Whether Ortho-Tri-Cyclen-21 has been Voluntarily

WDL 1 Barr Laboratories, Inc. Vol#: 1

02P-0395 Determine whether Ortho-Cyclen-21 Tablets,NDA 19 652 have

WDL 1 Barr Laboratories, Inc. Vol#: 1

02P-0414 Cefuroxime Axetil Tablets Oral suspension 125mg & 250mg ANDA

ACK 1 HFA-305 Vol#: 1

CP 1 The Weinberg Group Inc. Vol#: 1

02V-0240 Laser Light Show

AMD 1 Lazerus Laser Systems Vol#: 1